Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases

Cardiol J. 2021;28(6):979-982. doi: 10.5603/CJ.a2021.0138. Epub 2021 Oct 28.

Authors

Joanna Chochoł-Labun¹, Renata Wachnicka-Truty¹, Małgorzata Sinica-Latecka¹, Katarzyna Sikorska², Marek Koziński³

Affiliations

¹ Department of Cardiology and Internal Diseases, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Gdynia, Poland.
² Department of Tropical and Parasitic Diseases, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Gdynia, Poland.
³ Department of Cardiology and Internal Diseases, Institute of Maritime and Tropical Medicine, Medical University of Gdansk, Gdynia, Poland. [email protected].

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / therapeutic use*
COVID-19 Drug Treatment*
Female
Humans
Male
Middle Aged
Treatment Outcome

Substances

Antibodies, Monoclonal, Humanized
tocilizumab